International Paper Company

Executive Summary

BUY, Low conviction. Rated BUY, Low conviction. The setup is a battered cyclical packaging name with weak trailing EPS, but management still guides to $2.35B-$2.45B of North America adjusted EBITDA and sees Q3 sequential improvement despite an $85M Pine Hill hit. The stock is cheap on sales, but cash flow quality is poor and the earnings record is uneven, so this is a recovery trade rather than a high-confidence compounder.

Investment Thesis

The market is pricing IP like a structurally broken paper company when the nearer truth is a messy, cyclical packaging operator working through outages, conversions, restructuring, and acquisition integration. At $34.53, investors are paying 0.76x sales for a business that still expects $2.35B-$2.45B of FY26 adjusted EBITDA in North America and $900M-$1.0B in EMEA. That does not make IP a great business, but it does suggest the stock has overshot to the downside after a -13.76% one-month move and a slide to 31.3% below the 52-week high.

The first thing the case depends on is that recent operational pain is temporary, not the new baseline. Q2 supports that view. EBITDA was $0.55B, ahead of expectations, and North America absorbed $127M of outage costs. Management also said mill performance improved about 500 bps YoY, which matters because reliability is the difference between a low-return asset base and a decent one in this business. Q3 guidance of $555M-$585M in North America includes about an $85M Pine Hill hit, so a clean quarter after that should show stronger earnings power than trailing results imply.

The second dependency is that self-help offsets soft demand. Demand is not strong. Management explicitly cut its North America second-half demand assumption to effectively flat, and macro headwinds increased to about $150M. Even so, IP is still growing box volumes, up 1.7% YoY in Q2, and expects to outgrow industry by about 2% this year. EMEA is also not just a hope story anymore, with $210M+ of run-rate savings backed by 31 closures and 3,000+ net position reductions.

What keeps conviction low is simple: the income statement and cash flow statement are still ugly. FY2025 operating margin was only 2.1%, net margin 2.0%, EPS -6.71, and FCF was roughly break-even. The earnings record is uneven, with 5 misses in 8 quarters, so management has not earned the benefit of the doubt yet. This is why the stock is a BUY, not a high-conviction one. The upside case is a normalization story from depressed levels, not proof of a high-quality franchise.

Key Metrics

Financial Strength

The balance sheet is not the core problem, but it is not a source of comfort either. $9.7B of debt and 0.67 debt/equity are serviceable for a company of this scale, yet the real constraint is poor cash conversion, with FCF around break-even and only a 1.10 current ratio. That leaves less room for execution mistakes while Riverdale ramps, Pine Hill recovers, and NORPAC is integrated. Margin trajectory matters more than leverage optics here: with FY2025 operating margin at just 2.1%, even modest cost inflation or volume softness can erase profitability quickly.

Competitive Position

IP's moat comes from scale in corrugated packaging, a broad mill and box plant footprint, and customer relationships that reward reliability and service. That moat is real, but not wide. This is still a cyclical, capital-intensive business where returns are heavily shaped by plant uptime, fiber and freight costs, and local supply-demand balance. The best support for a better moat today is operational, not structural: management cited roughly 500 bps YoY improvement in mill performance and still expects to outgrow industry volume by about 2% in North America. Over 3 to 5 years, the position should hold, but it is unlikely to strengthen dramatically without sustained margin proof.

Management & Guidance

Management's current guide is specific and directionally credible, but credibility is not yet strong enough for a high-conviction call. The Q2 call tightened rather than abandoned the FY26 outlook, and the Q3 EBITDA ranges, $555M-$585M for North America and $230M-$250M for EMEA, are concrete. CFO Lance Loeffler said, "Our full year adjusted EBITDA outlook is now $2.35 billion to $2.45 billion. We have reduced the top end of the range by approximately $50 million, primarily based on the macro environment and the prolonged impact from the Middle East conflict." That is a measured adjustment, not a reset. The issue is the record: IP has 5 misses in the last 8 quarters, including several large misses, so management deserves partial credit for recent execution but not full trust yet.

Bull Case

• Q2 execution was better than expected, with total EBITDA at $0.55B and North America EBITDA of $425M despite $127M of outage costs.
• North America box volumes grew 1.7% YoY, and management still expects to outpace industry volume by about 2% for FY26.
• Riverdale conversion was completed on time, with ramp-up largely by year-end and full run-rate in Q1 2027, giving a visible earnings bridge beyond the current outage-heavy period.
• The stock trades below key reference points, 9.7% under the 200-day average and 42.5% below the 5-year high, which leaves room for recovery if Q3 and Q4 confirm the EBITDA trajectory.

Bear Case

• FY2025 profitability was weak, with 2.1% operating margin, 2.0% net margin, and EPS of -$6.71, which shows how little cushion the model has when pricing and costs move the wrong way.
• Cash flow quality is poor, with FCF around $0.0B and a Cash Flow Quality score of 8/100, limiting balance-sheet flexibility while execution projects are still underway.
• Management cut the top end of North America FY26 EBITDA by $50M and cited about $150M of macro headwinds from transportation, OCC, diesel, and medical costs.
• The earnings track record is inconsistent, with 5 misses in the last 8 quarters, including misses of -191.8% in 2025-10-30 and -128.6% in 2026-01-29.

Valuation & Price Target

Engine price target $53.65 (+55.4% vs current), Low confidence.

• P/S Multiple: $70.5 (41% weight)
• Quality-adjusted: $32.32 (20% weight)
• DCF: $27.43 (10% weight)

This aligns with the quant baseline BUY (Low conviction) and keeps the same cautious tone. The $53.65 quant target implies 55.4% upside, but confidence stays low because that target is partly supported by a P/S Multiple value of $70.5 while peer dispersion is wide at 5.8x and IP's own quality score is only 42/100. The more conservative read is that sales-based cheapness is real, but weak FY2025 EPS of -$6.71, FCF near $0.0B, and a choppy beat/miss record argue against treating peer-multiple upside as fully bankable. Sell-side consensus is bullish, but that is low-signal context, not the basis of the call.

Risk Assessment

Risk score 47/100 (Moderate). The biggest risk is that FY26 recovery slips again because Pine Hill and macro costs collide with flat demand, with $70M-$100M of 2H26 disruption and about $150M of macro headwinds already embedded in management's outlook.

The Bottom Line

IP rates a BUY with Low conviction. The stock is cheap enough, and the operational bridge to better EBITDA is visible enough, to justify buying weakness at $34.53. This is not a quality story today, it is a recovery story with real but uneven evidence. A move to HOLD would follow another material guide-down or failure to convert the guided Q3 EBITDA rebound into cleaner cash flow. A move to higher conviction would require sustained margin improvement, cleaner free cash flow, and a better earnings beat cadence.